You are here: Industry Insights > AD

News List

Stainless Steel for Pharmaceutical Applications: Grades, Properties, and Best Practices Muhammad Asim Niazi
September 12, 2025
Selecting appropriate material of construction is critical for product quality, safety, and regulatory compliance, in the manufacturing industry.
Green Transformation of the Pharmaceutical Industry: Can Continuous Manufacturing Outperform Traditional Production? Aiden
September 05, 2025
Assesses continuous manufacturing (CM) in pharma green transition, comparing efficiency gains with traditional production amid tech/regulatory barriers and ESG impacts.
Made-in-China New Drugs: The Game and Breakthrough in the Over - 4 - Billion Market Lezhi
September 05, 2025
Profiles 16 China-made blockbuster drugs exceeding ¥1B sales, highlighting intense PD-1 competition, EGFR tech innovation, and bispecific antibody/non-oncology surge.
Made-in-China New Drugs: Breaking Through the RMB 4-Billion Battlefield lezhi
September 05, 2025
In 2024, the "Billion-Yuan Club" of made-in-China first-in-class new drugs expanded to 16 members.
Green Transformation of the Pharmaceutical Industry: Can Continuous Manufacturing Outpace Traditional Production? Aiden
September 05, 2025
In recent years, the green transformation of the pharmaceutical industry has become a widely discussed topic, with continuous manufacturing emerging as one of the key technologies driving this shift.
Drug-Device Combination Products: Making a Step Towards Better Adherence Suzanne Elvidge
August 01, 2025
More than half of the world’s population takes at least one medication daily, but the safety and efficacy data from clinical trials isn’t always fully reflected in real world use.
Pneumatics in Pharma – Introduction, Applications and Advantages Muhammad Asim Niazi
July 08, 2025
Compressed-air systems provide precise, corrosion-resistant, clean operation for critical pharma applications like precision filling, packaging, and in explosive environments, boosting efficiency.
Radioconjugate Therapy: The Approval Process And the Market Landscap Suzanne Elvidge
August 22, 2025
Radioconjugates combine targeted ligands with radioisotopes, enabling precision cancer therapy and theranostics. The $7.5B market by 2033 demands strict FDA safety/CMC data for NDA/BLA approval.
Radioconjugates: Targeting for Precision Suzanne Elvidge
May 06, 2025
The development of radioconjugates – targeted molecules designed to carry radionuclides directly to cancerous cells, lowering systemic exposure and increasing the precision of treatment.
mRNA Technology for Vaccines and Broader Applications Saher Haider
May 06, 2025
Messenger RNA (mRNA) Technology has swiftly made its way to the field of vaccinology, offering a novel approach to immunization that differs fundamentally from traditional mechanisms of vaccination.